Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/2009
11/05/2009WO2009132863A1 Knock-in mouse for modelling blockade of human tnfalpha
11/05/2009WO2009132850A1 Armyworm insect resistance management in transgenic plants
11/05/2009WO2009132656A2 Design of specific ligands to sortilin
11/05/2009WO2009132510A1 Lipocalin-2 as a prognostic and diagnostic marker for heart and stroke risks
11/05/2009WO2009132499A1 Preparation of protein filling for making leather bu animal hair
11/05/2009WO2009132401A2 Citrullinated cytokines
11/05/2009WO2009112289A3 Cellular differentiation promotion
11/05/2009WO2009109643A3 Use of interleukin-1 conjugates in the treatment of diabetes
11/05/2009WO2009105780A3 Mntf peptide compositions and methods of use
11/05/2009WO2009102509A3 Vaccines and diagnostics for ehrlichia chaffeensis
11/05/2009WO2009088403A3 Nontoxic shiga-like toxin mutant compositions and methods
11/05/2009WO2009082243A3 Glycosyltransferases, polynucleotides encoding these and methods of use
11/05/2009WO2009059011A3 Hla-dr binding peptides and their uses
11/05/2009WO2009041831A9 PHAGE ϕMRU POLYNUCLEOTIDES AND POLYPEPTIDES AND USES THEREOF
11/05/2009WO2009029847A8 Compositions and methods of using proislet peptides and analogs thereof
11/05/2009WO2008141806A8 Methods and means for producing glycoproteins with altered glycosylation pattern in higher plants
11/05/2009WO2008113536A8 Neurotrophic peptides
11/05/2009WO2008036761A8 Anti-microbial defensin-related peptides and methods of use
11/05/2009WO2008033887A8 Methods for treating cancer
11/05/2009WO2007117215A8 Binder for c-reactive protein
11/05/2009WO2007098671A8 A method for preparing the primers for in vitro identifying mutations within larged vestibular aqueduct syndromic hearing loss pds gene and the use thereof
11/05/2009WO2007048103A9 Pkd ligands and polynucleotides encoding pkd ligands
11/05/2009US20090276921 Nucleic Acid Molecules Encoding Fatty Acid Desaturase Genes from Plants and Methods of Use
11/05/2009US20090276912 Transgenic plants having increased soluble solids, lycopene, and improved plant volume or yield, increased anthocyanin in leaves, seedling vigor; improved resistance to cold, heat, freezing, low nitrogen and phosphorus conditions, osmotic stresses such as drought, and high salt
11/05/2009US20090276863 Protein formulations comprising s1-5
11/05/2009US20090276160 using the crystal structures and structural coordinates to identify homologous proteins and to design or identify agents that can modulate the function of the HGFA
11/05/2009US20090275877 Method of Enhancing Electrotransport Polypeptide Flux By Amino Acid Substitution with Histidine
11/05/2009US20090275740 Novel collectin
11/05/2009US20090275738 Use of A33 antigens and jam-it
11/05/2009US20090275736 NMDAR Biomarkers for Diagnosis and Treatment of Traumatic Brain Injury and Other Disorders
11/05/2009US20090275735 Monoclonal antibodies to human ctla-8 (il-17a)
11/05/2009US20090275734 polynucleotides and polypeptides which are under-expressed in cancer and dysplasia delivered therapeutically to reduce the abnormal characteristics of cancer and dysplastic cells
11/05/2009US20090275733 Production of mustard seed protein isolate
11/05/2009US20090275732 Agent for improving circulatory disorder
11/05/2009US20090275649 Compositions And Methods For Identifying Modulars Of TRPV2
11/05/2009US20090275644 Novel adaptor protein that binds to mammalian toll-like receptor 3 and gene thereof
11/05/2009US20090275643 Tryptophanyl-tRNA synthetase-derived polypeptides useful for the regulation of angiogenesis
11/05/2009US20090275636 Picornavirus and uses thereof
11/05/2009US20090275521 Regulation of Microphage Migration Inhibitory Factor (MIF) Activity
11/05/2009US20090275518 G-csf polypeptides and uses thereof
11/05/2009US20090275517 G-csf polypeptides and uses thereof
11/05/2009US20090275513 Composition and method for preparing plasminogen
11/05/2009US20090275511 Analogs of ghrelin substituted at the n-terminal
11/05/2009US20090275510 Compositions and Methods for Inducing or Inhibiting Activities of Selected Human Cells
11/05/2009US20090275506 Long lasting natriuretic peptide derivatives
11/05/2009US20090275504 Pcsk9 proteins, fragments thereof and methods of modulating pcsk9 phosphorylation and low density lipoprotein (ldlr) degradation
11/05/2009US20090275503 Diastereomeric peptides for modulating t cell immunity
11/05/2009US20090275501 Somatostatin-dopamine chimeric analogs
11/05/2009US20090275498 Novel peptides
11/05/2009US20090275497 Method for identifying modulators of the activity of ion-channels receptors
11/05/2009US20090275481 Anchored Transferrin Fusion Protein Libraries
11/05/2009US20090275141 Affinity Adsorbents for Factor VIII and Von Willebrand's Factor
11/05/2009US20090275139 Materials and methods relating to the production and maintenance of cell lines
11/05/2009US20090275137 High affinity tcr proteins and methods
11/05/2009US20090275135 Mammalian cytokines; receptors; related reagents and methods
11/05/2009US20090275134 Compositions of active wnt protein
11/05/2009US20090275125 Human T1R2 Taste Receptor Nucleic Acids and Cells Containing These Nucleic Acids
11/05/2009US20090275123 Modified vitamin k-dependent polypeptides
11/05/2009US20090275122 Polypeptides having colanic acid-degrading activity
11/05/2009US20090275104 Genetically engineered glucanase for use in detergent industry, textiles and preparation of peptide antibiotics
11/05/2009US20090275102 homologous immunoreactive thio-disulfide oxidoreductases; fusion proteins; fluorescent, radioactive, or enzymatic labels
11/05/2009US20090275101 polynucleotides and polypeptides which are under-expressed in cancer and dysplasia delivered therapeutically to reduce the abnormal characteristics of cancer and dysplastic cells
11/05/2009US20090275092 Method for producing 4-hydroxy-l-isoleucine
11/05/2009US20090275083 Isolated peptides having phospholipase inhibitory activity
11/05/2009US20090275082 Mast Cell-Derived Membrane Proteins
11/05/2009US20090275069 polynucleotides and polypeptides which are under-expressed in cancer and dysplasia delivered therapeutically to reduce the abnormal characteristics of cancer and dysplastic cells
11/05/2009US20090275066 Immobilization of membrane porteins onto supports via an amphiphile
11/05/2009US20090275054 polynucleotides and polypeptides which are under-expressed in cancer and dysplasia delivered therapeutically to reduce the abnormal characteristics of cancer and dysplastic cells
11/05/2009US20090275049 EphA4 POLYPEPTIDE HAVING A NOVEL ACTIVITY AND USE THEREOF
11/05/2009US20090275046 Complement factor H protein as a biomarker of Parkinson's disease
11/05/2009US20090275033 Uses of BNIPXL-Beta in premature canities
11/05/2009US20090275030 Cell calcification suppressing proteins, and genes of the proteins
11/05/2009US20090275024 Novel centrerosome-associated protein and applications thereof
11/05/2009US20090275021 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis
11/05/2009US20090275020 Traceability of Cellular Cycle Anomalies Targeting Oncology and Neurodegeneration
11/05/2009US20090275019 polynucleotides and polypeptides which are under-expressed in cancer and dysplasia delivered therapeutically to reduce the abnormal characteristics of cancer and dysplastic cells
11/05/2009US20090274794 Gene Encoding Cell Wall Mannoprotein and use Thererof
11/05/2009US20090274729 Media for clostridium bacterium and processes for obtaining a clostridial toxin
11/05/2009US20090274727 Recombinant RSV Virus Expression Systems And Vaccines
11/05/2009US20090274719 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
11/05/2009US20090274718 Chimeric proteins that induce effects directed against viruses
11/05/2009US20090274717 Genes and proteins, and their use
11/05/2009US20090274716 Lage-1 tumor associated nucleic acids
11/05/2009US20090274714 Tumour-associated peptides binding to human leukocyte antigen (hla) class i or ii molecules and related anti-cancer vaccine
11/05/2009US20090274708 Recombinant Toxin Fragments
11/05/2009US20090274703 Methods of treating inflammation using IL-17 antagonists
11/05/2009US20090274701 Chlamydia pneumoniae polynucleotides and uses thereof
11/05/2009US20090274700 Il-31 receptor antibodies
11/05/2009US20090274699 Ul16 binding protein 4
11/05/2009US20090274694 Cytokine receptor zcytor17 multimers
11/05/2009US20090274691 Use of CD25 binding molecules in steroid-resistant patients
11/05/2009US20090274680 Human Phospholipases
11/05/2009US20090274671 Vector encoding human globin gene and use thereof in treatment of hemoglobinopathies
11/05/2009US20090274670 Dph2 gene deletion mutant and uses thereof
11/05/2009US20090274666 B7-h1, a novel immunoregulatory molecule
11/05/2009US20090274653 Interleukin-2 mutants with reduced toxicity
11/05/2009US20090274651 Therapeutic agent for infections, and treatment method using the same
11/05/2009US20090274632 Identification of human T2R receptors that respond to bitter compounds that elicit the bitter taste in compositions, and the use thereof in assays to identify compounds that inhibit (block) bitter taste in composition and use thereof
11/05/2009US20090274625 Compositions and Methods for The Treatment of Cancer
11/05/2009CA2725601A1 Supercharged proteins for cell penetration
1 ... 575 576 577 578 579 580 581 582 583 584 585 586 587 588 589 590 591 592 593 594 595 ... 2916